Article thumbnail

Antihypertensive medication versus health promotion for improving metabolic syndrome in preventing cardiovascular events: a success rate-oriented simulation study

By Yoichi Ohno, Satomi Shibazaki, Ryuichiro Araki, Takashi Miyazaki, Mayuko Hanyu, Makiko Satoh, Tsuneo Takenaka, Hirokazu Okada and Hiromichi Suzuki
Topics: Research Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3045871
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2008). [Study of clarifying incidence of lifestylerelated diseases and related complications and its medical expenses using government-managed health insurance data]. Nippon Eiseigaku Zasshi
  2. A: Community-based lifestyle modification of cardiovascular disease risks in middle-aged Japanese: a 27-month update.
  3. (2008). Adapting a Markov Monte Carlo simulation model for forecasting the number of coronary artery revascularization procedures in an era of rapidly changing technology and policy. BMC Med Inform Decis Mak
  4. (2008). AH: Trends in obesity and abdominal obesity among hypertensive and nonhypertensive adults in the United States. Am J Hypertens
  5. (2008). Assessing medication consultations, hypertension control, awareness, and treatment among elderly Asian community dwellers. Consult Pharm
  6. (2008). Blood pressure variability causes spurious identification of hypertension in clinical studies: a computer simulation study.
  7. (1981). Borrie MS: Modelling with Differential Equations.
  8. (2008). Counterweight Project Team: Evaluation of the Counterweight Programme for obesity management in primary care: a starting point for continuous improvement.
  9. (2010). Edeoga C: Principles and practice of nonpharmacological interventions to reduce cardiometabolic risk. Med Princ Pract
  10. (2006). Erlinger TP, Appel LJ: Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann Intern Med
  11. (2008). G: Financial incentive-based approaches for weight loss: a randomized trial. JAMA
  12. (2008). GA: Weight loss and blood pressure control (Pro). Hypertension
  13. (2003). Geleijnse JM: Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension
  14. (2004). Improvement of blood pressure control in a hypertension clinic: a 10-year follow-up study. J Hum Hypertens
  15. (2007). Influence of hypertension on the incidence of cardiovascular disease in two rural communities in Japan: the Tanno-Sobetsu study. Hypertens Res
  16. (2004). Japanese Society of Hypertension guidelines for the management of hypertension (JSH
  17. (2009). Kamide K: High-normal blood pressure and the risk of cardiovascular disease.
  18. (2007). Kiyohara Y: Impact of metabolic syndrome on the development of cardiovascular disease in a general Japanese population: the Hisayama study. Stroke
  19. (2003). Lifestyle modification and blood pressure control: is the glass half full or half empty? JAMA
  20. (2002). Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA
  21. (2007). Matsuzawa Y: Metabolic syndrome: clinical concept and molecular basis. Ann Med
  22. (2004). Measuring adherence to practice guidelines for the management of hypertension: an evaluation of the literature. Hypertension
  23. (2005). Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese men–the Tanno and Sobetsu Study. Hypertens Res
  24. (1991). NJ: By how much does dietary salt reduction lower blood pressure? III–Analysis of data from trials of salt reduction.
  25. (2007). Relationship between visceral fat and cardiovascular disease risk factors: the Tanno and Sobetsu study. Hypertension Research
  26. (2003). Roccella EJ: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA
  27. (2004). S: Ageassociated increase in oxidative stress and nuclear factor kappaB activation are attenuated in rat liver by regular exercise.
  28. (2006). Saruta T: Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-combi) study. Hypertension Research
  29. (2008). Siscovick DS: Metabolic syndrome and mortality in older adults: the Cardiovascular Health Study. Arch Intern Med
  30. (2006). Speroff T: Improving blood pressure control through provider education, provider alerts, and patient education: a cluster randomized trial. Ann Intern Med
  31. (2003). T: Impact of elevated blood pressure on mortality from all causes, cardiovascular diseases, heart disease and stroke among Japanese: 14 year follow-up of randomly selected population from Japanese – Nippon data 80. J Hum Hypertens
  32. (2002). The development of a simulation model of primary prevention strategies for coronary heart disease. Health Care Management Science
  33. (2009). The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH
  34. (2006). Ueshima H: Age-specific effects of systolic and diastolic blood pressures on mortality due to cardiovascular diseases among
  35. (2003). Validity of the JNC VI recommendations for the management of hypertension in a general population of Japanese elderly: the Hisayama study. Arch Intern Med
  36. (2004). Valiyeva E, Carson JL: Effects of prehypertension on admissions and deaths: a simulation. Arch Intern Med
  37. (2003). World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension.